Table 1.
Modification | Regulation | Signaling Pathway |
---|---|---|
Naturally Occurring | up | neurotrophic signaling TLR2-mediated signaling TLR9 pathway VEGF-A pathway |
down |
Aurora-B cell cycle regulation
Cdc20 deubiquitination Cdc20 ubiquitination cyclinB1 ubiquitination ---> anaphase onset Fzr1 ---> cyclin B1 degradation Metaphase to Anaphase transition securin degradation Usp44 ---> Cdc20 |
|
Desialylation | up | Apo2L pathway Fas pathway insulin ---> ERK neurotrophic signaling TLR9 pathway |
down |
Aurora-B cell cycle regulation
Cdc20 deubiquitination Cdc20 ubiquitination cyclinB1 ubiquitination ---> anaphase onset Fzr1 ---> cyclin B1 degradation Metaphase to Anaphase transition securin degradation Usp44 ---> Cdc20 |
|
Acetylation | up | alpha IIb beta3 ---> Rac1 alpha IIb beta3 pathway angiotensin II ---> DAG, CaMKII Aurora-A activation, substrates, and degradation Aurora-A cell cycle regulation B-cell antigen receptor pathway BCR ---> ERK BDNF ---trkB---> MAPK cascade beta-glucan ---> AKT-1 Fas pathway G-alpha-q ---> arachidonic acid, ERK insulin ---> ERK insulin pathway insulin ---Shc---> MAPK cascade KSR scaffold complex neurotensin pathway neurotrophic signaling p38 pathway p53 pathway PDGF A ---> ERK PDGF B ---> ERK PKC ---> ERK1, ERK2 POSH ---> JNK1, JNK2 PRL ---Src, FAK1---> ERK RANKL ---> p38 RANKL pathway Tiam1 ---> p38alpha TLR2 ---Rac1--->AKT TLR2-mediated signaling TLR3 pathway TLR9 pathway tuberin pathway VEGF-A pathway |
down | Aurora-B cell cycle regulation | |
Oxidation | up | AR pathway Fas pathway HIF-1alpha pathway IRAK-1 ---MKK3---> TNF p38 pathway p53 pathway PKC ---> ERK1, ERK2 RANKL ---> p38 RANKL pathway TLR2-mediated signaling TLR3 pathway TLR9 pathway |
down | - |